Price T Rowe Associates Inc Crispr Therapeutics Ag Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Price T Rowe Associates Inc holds 23,763 shares of CRSP stock, worth $967,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,763
Previous 420,695 94.35%
Holding current value
$967,629
Previous $22.7 Million 95.08%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$44.62 - $62.75 $17.7 Million - $24.9 Million
-396,932 Reduced 94.35%
23,763 $1.12 Million
Q2 2024

Aug 14, 2024
SELL
$51.17 - $68.18 $9.19 Million - $12.2 Million
-179,539 Reduced 29.91%
420,695 $22.7 Million
Q1 2024

May 15, 2024
SELL
$60.67 - $89.12 $16 Million - $23.5 Million
-264,112 Reduced 30.56%
600,234 $40.9 Million
Q4 2023

Feb 14, 2024
SELL
$38.62 - $72.18 $204,338 - $381,904
-5,291 Reduced 0.61%
864,346 $54.1 Million
Q3 2023

Nov 14, 2023
SELL
$45.39 - $59.0 $578,177 - $751,542
-12,738 Reduced 1.44%
869,637 $39.5 Million
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $9.58 Million - $14.9 Million
-220,346 Reduced 19.98%
882,375 $49.5 Million
Q1 2023

May 15, 2023
SELL
$41.0 - $56.12 $825,207 - $1.13 Million
-20,127 Reduced 1.79%
1,102,721 $49.9 Million
Q4 2022

Feb 14, 2023
SELL
$39.19 - $65.67 $2.53 Million - $4.24 Million
-64,614 Reduced 5.44%
1,122,848 $45.6 Million
Q3 2022

Nov 14, 2022
SELL
$61.1 - $83.78 $112 Million - $153 Million
-1,827,089 Reduced 60.61%
1,187,462 $77.6 Million
Q2 2022

Aug 15, 2022
BUY
$43.23 - $73.83 $79.9 Million - $136 Million
1,848,437 Added 158.51%
3,014,551 $183 Million
Q1 2022

May 16, 2022
BUY
$53.19 - $79.24 $4.01 Million - $5.97 Million
75,301 Added 6.9%
1,166,114 $73.2 Million
Q4 2021

Feb 14, 2022
SELL
$70.09 - $111.29 $6.58 Million - $10.5 Million
-93,916 Reduced 7.93%
1,090,813 $82.7 Million
Q3 2021

Nov 15, 2021
SELL
$110.2 - $156.64 $500,748 - $711,772
-4,544 Reduced 0.38%
1,184,729 $133 Million
Q2 2021

Aug 16, 2021
SELL
$100.84 - $161.89 $11 Million - $17.7 Million
-109,056 Reduced 8.4%
1,189,273 $193 Million
Q1 2021

May 17, 2021
SELL
$110.72 - $210.04 $52.7 Million - $100 Million
-476,107 Reduced 26.83%
1,298,329 $158 Million
Q4 2020

Feb 16, 2021
BUY
$79.67 - $173.23 $141 Million - $307 Million
1,774,436 New
1,774,436 $272 Million

Others Institutions Holding CRSP

# of Institutions
490
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email